Posted by floatingbridge on May 12, 2011, at 13:32:09
In reply to Re: TDp Journal Article #2 + #3 » floatingbridge, posted by SLS on May 12, 2011, at 6:23:54
Scott, you might imagine that I'm still trying to work through the science part. This article is timely because I had independently concluded that snri's somehow made me worse. And dysphoric was becoming like a middle name. Those bouts really have lessened, yet depression itself returned both mentally and physically. I think the authors (and I) would agree that
depressive illnesses have their own course, indeed very often and unfortunately worsening over time. So abstinence from treatment is not a desirable option for me. Hence looking at other agents is wise and proactive.In my own situation, I'm hoping that the emsam (segeline) with some track record of neuroprotection is a wise enough choice.
And a question then, (given the lack of a
fuller comprehension): would the scatter-shot less selective maoi's be seen as more acceptable and perhaps have longer efficacy than a more selective yet also perhaps more idiosyncratic agent?And, can people actually be genetically tested? I mean regular people, not millionaires or test subjects.
fb
(The questions aren't just for you Scott, but meant for discussion.)
* and whoever gazes at the stars will never again be quite alone...
c-ptsd & attendant health concerns
poster:floatingbridge
thread:985133
URL: http://www.dr-bob.org/babble/20110502/msgs/985153.html